Rockwell Medical
Launch date
Employees
Market cap
$129m
Enterprise valuation
$131m (Public information from Sep 2024)
Share price
$4.14 RMTI
Wixom Michigan (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 61.3m | 62.2m | 61.9m | 72.8m | 83.6m | 100m | 109m |
| % growth | (3 %) | 1 % | - | 18 % | 15 % | 20 % | 9 % |
| EBITDA | (34.1m) | (26.7m) | (27.8m) | (16.7m) | (5.0m) | - | - |
| % EBITDA margin | (56 %) | (43 %) | (45 %) | (23 %) | (6 %) | - | - |
| Profit | (34.1m) | (30.9m) | (32.7m) | (18.7m) | (8.4m) | (<1m) | 2.4m |
| % profit margin | (56 %) | (50 %) | (53 %) | (26 %) | (10 %) | (1 %) | 2 % |
| EV / revenue | 2.5x | 1.5x | 0.6x | 0.2x | 0.6x | 0.9x | 0.8x |
| EV / EBITDA | -4.6x | -3.5x | -1.4x | -0.7x | -10.7x | - | - |
| R&D budget | 6.9m | 7.1m | 6.8m | 3.1m | 1.1m | - | - |
| R&D % of revenue | 11 % | 11 % | 11 % | 4 % | 1 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| N/A | $30.0m | Early VC | |
| N/A | $20.0m | Post IPO Debt | |
| N/A | $15.0m | Post IPO Equity | |
* | $15.0m | Post IPO Equity | |
| Total Funding | $30.0m | ||
Related Content
Recent News about Rockwell Medical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.